Loading…

Comparison of 99mTc-N-Pyridoxyl-5-Methyltryptophan and 99mTc-N-(3-Bromo-2,4,6-trimethylacetanilide)-Iminodiacetate as Hepatobiliary Radiopharmaceuticals in Rats

99mTc - N - (3-bromo-2,4,6-trimethylacetanilide)iminodiacetate (I) and 99mTc-N-pyridoxyl-5-methyl-tryptophan (II) have been described as having optimal properties as hepatobiliary radiopharmaceuticals. This study compared specificity for hepatobiliary excretion, blood disappearance, rates of biliary...

Full description

Saved in:
Bibliographic Details
Published in:Journal of pharmaceutical sciences 1984-12, Vol.73 (12), p.1861-1863
Main Authors: Fritzberg, Alan R., Bloedow, Duane C., Eshima, Dennis, Johnson, Dennis L.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c2349-aad59b97b813fa4c4e89536330980db73cf0e3ca501634d8af5de1e1ecaaaf9d3
container_end_page 1863
container_issue 12
container_start_page 1861
container_title Journal of pharmaceutical sciences
container_volume 73
creator Fritzberg, Alan R.
Bloedow, Duane C.
Eshima, Dennis
Johnson, Dennis L.
description 99mTc - N - (3-bromo-2,4,6-trimethylacetanilide)iminodiacetate (I) and 99mTc-N-pyridoxyl-5-methyl-tryptophan (II) have been described as having optimal properties as hepatobiliary radiopharmaceuticals. This study compared specificity for hepatobiliary excretion, blood disappearance, rates of biliary appearance, and pharmacokinetic parameters including hepatic clearance, volumes of distribution, and mean residence times in normal and sulfobromophthalein-treated rats. The specificity of I was higher as indicated by 94% in the bile at 90min compared to 91% for II in normal rats and a urine excretion of 0.3% for I compared with 1.9% for II. In sulfobromophthalein-treated animals, urine excretion increases were only to 0.5 and 3.0% for I and II, respectively. In control rats, blood disappearance was similar for both I and II, but II disappeared faster in treated animals. The clearance of II was 70 mL/min/kg in normal and 47 mL/min/kg in treated rats; clearance of I was 51 and 30 mL/min/kg in normal and treated rats, respectively. Volumes of distribution were larger for II. Compound I was superior in specificity while II was superior in clearance and excretion kinetics.
doi_str_mv 10.1002/jps.2600731259
format article
fullrecord <record><control><sourceid>wiley_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1002_jps_2600731259</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022354915464925</els_id><sourcerecordid>JPS2600731259</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2349-aad59b97b813fa4c4e89536330980db73cf0e3ca501634d8af5de1e1ecaaaf9d3</originalsourceid><addsrcrecordid>eNqFkEFP3DAQha2qlbqlXHvOgQOV8NaO4yQ-0lVhqSisFiqO1qztCEMSR7bbkn_DT8VLqkU9VMgHy-Pvzbx5CH2iZE4Jyb_cDWGel4RUjOZcvEEzynOCS0Krt2iWgBwzXoj36EMId4SQknA-Q48L1w3gbXB95ppMiO5a4Qu8Gr3V7mFsMcc_TLwd2-jHIbrhFvoMer0DDxn-6l3ncH5UHJU4ets946BMhN62VpvP-KyzvdP2uRZNBiFbmgGi26R_8GO2Bm23rX2XkF_RKmhDZvtUj-Ejetekp9n_e--hnyffrhdLfH55erY4PscqZ4XAAJqLjag2NWUNFKowteCsZIyImuhNxVRDDFPACS1ZoWtouDY0HQUAjdBsD82nvsq7ELxp5JB2Se4kJXKbr0z5ypd8k-BgEgwQkuHGQ69s2KnqmnFWV69ivChytsXEhP2xrRlfmS2_r67-cYInrQ3RPOy04O9lWbGKy5uLU3m1Xp4sVpzJdeLriTcpz9_WeBmUNb0y2nqjotTO_m_pJ_ZQvL0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Comparison of 99mTc-N-Pyridoxyl-5-Methyltryptophan and 99mTc-N-(3-Bromo-2,4,6-trimethylacetanilide)-Iminodiacetate as Hepatobiliary Radiopharmaceuticals in Rats</title><source>Wiley Online Library Journals</source><creator>Fritzberg, Alan R. ; Bloedow, Duane C. ; Eshima, Dennis ; Johnson, Dennis L.</creator><creatorcontrib>Fritzberg, Alan R. ; Bloedow, Duane C. ; Eshima, Dennis ; Johnson, Dennis L.</creatorcontrib><description>99mTc - N - (3-bromo-2,4,6-trimethylacetanilide)iminodiacetate (I) and 99mTc-N-pyridoxyl-5-methyl-tryptophan (II) have been described as having optimal properties as hepatobiliary radiopharmaceuticals. This study compared specificity for hepatobiliary excretion, blood disappearance, rates of biliary appearance, and pharmacokinetic parameters including hepatic clearance, volumes of distribution, and mean residence times in normal and sulfobromophthalein-treated rats. The specificity of I was higher as indicated by 94% in the bile at 90min compared to 91% for II in normal rats and a urine excretion of 0.3% for I compared with 1.9% for II. In sulfobromophthalein-treated animals, urine excretion increases were only to 0.5 and 3.0% for I and II, respectively. In control rats, blood disappearance was similar for both I and II, but II disappeared faster in treated animals. The clearance of II was 70 mL/min/kg in normal and 47 mL/min/kg in treated rats; clearance of I was 51 and 30 mL/min/kg in normal and treated rats, respectively. Volumes of distribution were larger for II. Compound I was superior in specificity while II was superior in clearance and excretion kinetics.</description><identifier>ISSN: 0022-3549</identifier><identifier>EISSN: 1520-6017</identifier><identifier>DOI: 10.1002/jps.2600731259</identifier><identifier>CODEN: JPMSAE</identifier><language>eng</language><publisher>Washington: Elsevier Inc</publisher><subject>Applied sciences ; Biological and medical sciences ; Contrast media. Radiopharmaceuticals ; Exact sciences and technology ; Hepatobiliary radiopharmaceuticals-99mTc-labeled compounds compared ; Hepatobiliary radiopharmaceuticals—99mTc-labeled compounds compared, sulfobromophthalein-treated and normal rats ; Medical sciences ; Other techniques and industries ; Pharmacology. Drug treatments ; Radiopharmaceuticals-99mTc-labeled hepatobiliary compounds compared ; Radiopharmaceuticals—99mTc-labeled hepatobiliary compounds compared, sulfobromophthalein-treated and normal rats ; rats ; Sulfobromophthalein-effect on hepatobiliary radiopharmaceuticals ; sulfobromophthalein-treated and normal rats ; Sulfobromophthalein—effect on hepatobiliary radiopharmaceuticals, rats</subject><ispartof>Journal of pharmaceutical sciences, 1984-12, Vol.73 (12), p.1861-1863</ispartof><rights>1984 Wiley‐Liss, Inc., A Wiley Company</rights><rights>Copyright © 1984 Wiley‐Liss, Inc., A Wiley Company</rights><rights>1986 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2349-aad59b97b813fa4c4e89536330980db73cf0e3ca501634d8af5de1e1ecaaaf9d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjps.2600731259$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjps.2600731259$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=8544237$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=8835387$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>Fritzberg, Alan R.</creatorcontrib><creatorcontrib>Bloedow, Duane C.</creatorcontrib><creatorcontrib>Eshima, Dennis</creatorcontrib><creatorcontrib>Johnson, Dennis L.</creatorcontrib><title>Comparison of 99mTc-N-Pyridoxyl-5-Methyltryptophan and 99mTc-N-(3-Bromo-2,4,6-trimethylacetanilide)-Iminodiacetate as Hepatobiliary Radiopharmaceuticals in Rats</title><title>Journal of pharmaceutical sciences</title><addtitle>J. Pharm. Sci</addtitle><description>99mTc - N - (3-bromo-2,4,6-trimethylacetanilide)iminodiacetate (I) and 99mTc-N-pyridoxyl-5-methyl-tryptophan (II) have been described as having optimal properties as hepatobiliary radiopharmaceuticals. This study compared specificity for hepatobiliary excretion, blood disappearance, rates of biliary appearance, and pharmacokinetic parameters including hepatic clearance, volumes of distribution, and mean residence times in normal and sulfobromophthalein-treated rats. The specificity of I was higher as indicated by 94% in the bile at 90min compared to 91% for II in normal rats and a urine excretion of 0.3% for I compared with 1.9% for II. In sulfobromophthalein-treated animals, urine excretion increases were only to 0.5 and 3.0% for I and II, respectively. In control rats, blood disappearance was similar for both I and II, but II disappeared faster in treated animals. The clearance of II was 70 mL/min/kg in normal and 47 mL/min/kg in treated rats; clearance of I was 51 and 30 mL/min/kg in normal and treated rats, respectively. Volumes of distribution were larger for II. Compound I was superior in specificity while II was superior in clearance and excretion kinetics.</description><subject>Applied sciences</subject><subject>Biological and medical sciences</subject><subject>Contrast media. Radiopharmaceuticals</subject><subject>Exact sciences and technology</subject><subject>Hepatobiliary radiopharmaceuticals-99mTc-labeled compounds compared</subject><subject>Hepatobiliary radiopharmaceuticals—99mTc-labeled compounds compared, sulfobromophthalein-treated and normal rats</subject><subject>Medical sciences</subject><subject>Other techniques and industries</subject><subject>Pharmacology. Drug treatments</subject><subject>Radiopharmaceuticals-99mTc-labeled hepatobiliary compounds compared</subject><subject>Radiopharmaceuticals—99mTc-labeled hepatobiliary compounds compared, sulfobromophthalein-treated and normal rats</subject><subject>rats</subject><subject>Sulfobromophthalein-effect on hepatobiliary radiopharmaceuticals</subject><subject>sulfobromophthalein-treated and normal rats</subject><subject>Sulfobromophthalein—effect on hepatobiliary radiopharmaceuticals, rats</subject><issn>0022-3549</issn><issn>1520-6017</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1984</creationdate><recordtype>article</recordtype><recordid>eNqFkEFP3DAQha2qlbqlXHvOgQOV8NaO4yQ-0lVhqSisFiqO1qztCEMSR7bbkn_DT8VLqkU9VMgHy-Pvzbx5CH2iZE4Jyb_cDWGel4RUjOZcvEEzynOCS0Krt2iWgBwzXoj36EMId4SQknA-Q48L1w3gbXB95ppMiO5a4Qu8Gr3V7mFsMcc_TLwd2-jHIbrhFvoMer0DDxn-6l3ncH5UHJU4ets946BMhN62VpvP-KyzvdP2uRZNBiFbmgGi26R_8GO2Bm23rX2XkF_RKmhDZvtUj-Ejetekp9n_e--hnyffrhdLfH55erY4PscqZ4XAAJqLjag2NWUNFKowteCsZIyImuhNxVRDDFPACS1ZoWtouDY0HQUAjdBsD82nvsq7ELxp5JB2Se4kJXKbr0z5ypd8k-BgEgwQkuHGQ69s2KnqmnFWV69ivChytsXEhP2xrRlfmS2_r67-cYInrQ3RPOy04O9lWbGKy5uLU3m1Xp4sVpzJdeLriTcpz9_WeBmUNb0y2nqjotTO_m_pJ_ZQvL0</recordid><startdate>198412</startdate><enddate>198412</enddate><creator>Fritzberg, Alan R.</creator><creator>Bloedow, Duane C.</creator><creator>Eshima, Dennis</creator><creator>Johnson, Dennis L.</creator><general>Elsevier Inc</general><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley</general><general>American Pharmaceutical Association</general><scope>BSCLL</scope><scope>IQODW</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>198412</creationdate><title>Comparison of 99mTc-N-Pyridoxyl-5-Methyltryptophan and 99mTc-N-(3-Bromo-2,4,6-trimethylacetanilide)-Iminodiacetate as Hepatobiliary Radiopharmaceuticals in Rats</title><author>Fritzberg, Alan R. ; Bloedow, Duane C. ; Eshima, Dennis ; Johnson, Dennis L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2349-aad59b97b813fa4c4e89536330980db73cf0e3ca501634d8af5de1e1ecaaaf9d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1984</creationdate><topic>Applied sciences</topic><topic>Biological and medical sciences</topic><topic>Contrast media. Radiopharmaceuticals</topic><topic>Exact sciences and technology</topic><topic>Hepatobiliary radiopharmaceuticals-99mTc-labeled compounds compared</topic><topic>Hepatobiliary radiopharmaceuticals—99mTc-labeled compounds compared, sulfobromophthalein-treated and normal rats</topic><topic>Medical sciences</topic><topic>Other techniques and industries</topic><topic>Pharmacology. Drug treatments</topic><topic>Radiopharmaceuticals-99mTc-labeled hepatobiliary compounds compared</topic><topic>Radiopharmaceuticals—99mTc-labeled hepatobiliary compounds compared, sulfobromophthalein-treated and normal rats</topic><topic>rats</topic><topic>Sulfobromophthalein-effect on hepatobiliary radiopharmaceuticals</topic><topic>sulfobromophthalein-treated and normal rats</topic><topic>Sulfobromophthalein—effect on hepatobiliary radiopharmaceuticals, rats</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fritzberg, Alan R.</creatorcontrib><creatorcontrib>Bloedow, Duane C.</creatorcontrib><creatorcontrib>Eshima, Dennis</creatorcontrib><creatorcontrib>Johnson, Dennis L.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>CrossRef</collection><jtitle>Journal of pharmaceutical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fritzberg, Alan R.</au><au>Bloedow, Duane C.</au><au>Eshima, Dennis</au><au>Johnson, Dennis L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparison of 99mTc-N-Pyridoxyl-5-Methyltryptophan and 99mTc-N-(3-Bromo-2,4,6-trimethylacetanilide)-Iminodiacetate as Hepatobiliary Radiopharmaceuticals in Rats</atitle><jtitle>Journal of pharmaceutical sciences</jtitle><addtitle>J. Pharm. Sci</addtitle><date>1984-12</date><risdate>1984</risdate><volume>73</volume><issue>12</issue><spage>1861</spage><epage>1863</epage><pages>1861-1863</pages><issn>0022-3549</issn><eissn>1520-6017</eissn><coden>JPMSAE</coden><abstract>99mTc - N - (3-bromo-2,4,6-trimethylacetanilide)iminodiacetate (I) and 99mTc-N-pyridoxyl-5-methyl-tryptophan (II) have been described as having optimal properties as hepatobiliary radiopharmaceuticals. This study compared specificity for hepatobiliary excretion, blood disappearance, rates of biliary appearance, and pharmacokinetic parameters including hepatic clearance, volumes of distribution, and mean residence times in normal and sulfobromophthalein-treated rats. The specificity of I was higher as indicated by 94% in the bile at 90min compared to 91% for II in normal rats and a urine excretion of 0.3% for I compared with 1.9% for II. In sulfobromophthalein-treated animals, urine excretion increases were only to 0.5 and 3.0% for I and II, respectively. In control rats, blood disappearance was similar for both I and II, but II disappeared faster in treated animals. The clearance of II was 70 mL/min/kg in normal and 47 mL/min/kg in treated rats; clearance of I was 51 and 30 mL/min/kg in normal and treated rats, respectively. Volumes of distribution were larger for II. Compound I was superior in specificity while II was superior in clearance and excretion kinetics.</abstract><cop>Washington</cop><pub>Elsevier Inc</pub><doi>10.1002/jps.2600731259</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-3549
ispartof Journal of pharmaceutical sciences, 1984-12, Vol.73 (12), p.1861-1863
issn 0022-3549
1520-6017
language eng
recordid cdi_crossref_primary_10_1002_jps_2600731259
source Wiley Online Library Journals
subjects Applied sciences
Biological and medical sciences
Contrast media. Radiopharmaceuticals
Exact sciences and technology
Hepatobiliary radiopharmaceuticals-99mTc-labeled compounds compared
Hepatobiliary radiopharmaceuticals—99mTc-labeled compounds compared, sulfobromophthalein-treated and normal rats
Medical sciences
Other techniques and industries
Pharmacology. Drug treatments
Radiopharmaceuticals-99mTc-labeled hepatobiliary compounds compared
Radiopharmaceuticals—99mTc-labeled hepatobiliary compounds compared, sulfobromophthalein-treated and normal rats
rats
Sulfobromophthalein-effect on hepatobiliary radiopharmaceuticals
sulfobromophthalein-treated and normal rats
Sulfobromophthalein—effect on hepatobiliary radiopharmaceuticals, rats
title Comparison of 99mTc-N-Pyridoxyl-5-Methyltryptophan and 99mTc-N-(3-Bromo-2,4,6-trimethylacetanilide)-Iminodiacetate as Hepatobiliary Radiopharmaceuticals in Rats
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T14%3A33%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparison%20of%2099mTc-N-Pyridoxyl-5-Methyltryptophan%20and%2099mTc-N-(3-Bromo-2,4,6-trimethylacetanilide)-Iminodiacetate%20as%20Hepatobiliary%20Radiopharmaceuticals%20in%20Rats&rft.jtitle=Journal%20of%20pharmaceutical%20sciences&rft.au=Fritzberg,%20Alan%20R.&rft.date=1984-12&rft.volume=73&rft.issue=12&rft.spage=1861&rft.epage=1863&rft.pages=1861-1863&rft.issn=0022-3549&rft.eissn=1520-6017&rft.coden=JPMSAE&rft_id=info:doi/10.1002/jps.2600731259&rft_dat=%3Cwiley_cross%3EJPS2600731259%3C/wiley_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2349-aad59b97b813fa4c4e89536330980db73cf0e3ca501634d8af5de1e1ecaaaf9d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true